STRATA Skin Sciences, Inc. (SSKN): auditor change — Strata Skin Sciences replaces auditor: Marcum resigns, CBIZ engaged

STRATA Skin Sciences, Inc.

Marcum LLP resigned as independent auditor on April 23, 2025; CBIZ CPAs P.C. engaged same day with Audit Committee approval.
No disagreements with Marcum on accounting principles or financial statement disclosure during FY2024/2023 or through resignation.
Prior material weakness in internal controls (lack of detailed management review) was reported; no other reportable events.
Marcum's audit reports for FY2024 and FY2023 were unqualified and not modified as to uncertainty or scope.
Marcum's resignation followed CBIZ's acquisition of Marcum's attest business on November 1, 2024.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

STRATA Skin Sciences, Inc. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

On April 23, 2025, upon Marcum’s resignation as auditors of the Company and with the approval of the Company’s Audit Committee, CBIZ CPAs P.C. was engaged as the Company’s independent registered public accounting firm for the year ending December 31, 2025.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marcum LLP resigned as auditor of STRATA Skin Sciences, Inc..

Action: resignation
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

On April 23, 2025, Strata Skin Sciences, Inc. (the “Company”) was notified by Marcum LLP (“Marcum”) that Marcum resigned as the independent registered accounting firm of the Company.

View on SEC.gov

Browse all auditor changes →

STRATA Skin Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-25-015780

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.